Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250 | 905 | 919 | 1,252 | 270 |
| Marketable Securities | 31 | 30 | 31 | 32 | 32 |
| Receivables | 45 | 29 | 52 | 56 | 30 |
| TOTAL | $416 | $1,079 | $1,139 | $1,526 | $534 |
| Non-Current Assets | |||||
| PPE Net | 78 | N/A | N/A | N/A | 1 |
| Investments And Advances | 2 | 0 | 0 | 0 | 0 |
| Intangibles | 33 | 32 | 35 | 36 | 38 |
| TOTAL | $113 | $32 | $35 | $36 | $39 |
| Total Assets | $529 | $1,111 | $1,174 | $1,563 | $574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 490 | 1,292 | 1,161 | 1,101 | 1,055 |
| Accrued Expenses | 228 | 202 | 157 | 162 | 246 |
| Other current liabilities | 1,344 | N/A | N/A | N/A | N/A |
| TOTAL | $2,062 | $1,494 | $1,318 | $1,263 | $1,301 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,062 | $1,494 | $1,318 | $1,263 | $1,301 |
| Shareholders' Equity | |||||
| Common Shares | 39,593 | 38,053 | 37,534 | 36,951 | 36,036 |
| Retained earnings | -52,971 | -49,782 | -50,221 | -49,425 | -48,587 |
| Other shareholders' equity | 5,590 | 5,335 | 6,330 | 6,690 | 5,742 |
| TOTAL | $-1,533 | $-382 | $-144 | $300 | $-727 |
| Total Liabilities And Equity | $529 | $1,111 | $1,174 | $1,563 | $573 |